MPox | ISARIC

First validated tool to measure stigma during multiple infectious disease outbreaks published

by Isobel Young | May 31, 2025 | News, Publications

The new RAPID Stigma Scales, led by researchers at the PSI, will help health professionals to monitor stigma in disease outbreak settings, improving outbreak responses globally. Researchers from the Pandemic Sciences Institute (PSI) have today published a new...

MOSAIC study provides new insights into mpox clinical outcomes and transmission

by Asia Mace | Jan 17, 2025 | News

The European observational study, MOSAIC, provides evidence on how the clade IIb mpox virus affects patients and the risks of onward transmission In May 2022, a new variant of the mpox virus caused a global outbreak. This variant, known as clade IIb, differs from the...

First validated tool to measure stigma during multiple infectious disease outbreaks published

MOSAIC study provides new insights into mpox clinical outcomes and transmission

Experiences and challenges with the new European Clinical Trials Regulation

Community Involvement in an Outbreak—One Year on for Mpox

MOSAIC Clade 2b Mpox cohort study: Clinical Characterisation and Outcomes

First validated tool to measure stigma during multiple infectious disease outbreaks published

MOSAIC study provides new insights into mpox clinical outcomes and transmission

Experiences and challenges with the new European Clinical Trials Regulation

Community Involvement in an Outbreak—One Year on for Mpox

MOSAIC Clade 2b Mpox cohort study: Clinical Characterisation and Outcomes

Cookies Policy